Pricing Log in Create free account
Saturday 17 October 2026 Export IDXX’s income statement to Excel — free account

IDEXX Laboratories, Inc.

IDXX Healthcare Diagnostics & Research

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.

560.36 13.18 +2.41%
Market cap
$43.1B
P/E
39.1×
Fwd P/E
38.3×
Dividend yield
—
F-score
8/9
Altman Z
24.09
Beneish M
−2.50
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

IDEXX Laboratories, Inc. (IDXX) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, IDEXX Laboratories, Inc. (IDXX) trades at a price to free cash flow of 35.8×. Over the past ten years it has ranged from 32.2× (September 2026) to 112× (February 2023); the current reading is higher than 2% of that period. That is in line with the Diagnostics & Research industry median of 35.8× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 56.9× 20.30%
FY2024 47.3× (20.71%)
FY2023 59.6× (32.53%)
FY2022 88.4× (0.50%)
FY2021 88.8× 12.53%
FY2020 78.9× 4.17%
FY2019 75.8× 28.89%
FY2018 58.8× 25.89%
FY2017 46.7× 21.34%
FY2016 38.5× (20.93%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 33.6× (20.56%)
Mar 2026 42.3× (25.64%)
Dec 2025 56.9× (4.05%)
Sep 2025 59.3× (4.15%)
42 more quarters

Against its own ten years

Low 32.2× High 112×
Ten-year median 62.1×
Current reading's percentile 2

Price to free cash flow against peers

Company Price to free cash flow
DGX Quest Diagnostics Incorporated compare 19.3×
IQV IQVIA Holdings Inc. compare 19.6×
LH Labcorp Holdings Inc. compare 25.2×
IDXX IDEXX Laboratories, Inc. 35.8×
MTD Mettler-Toledo International, Inc. compare 37.8×
A Agilent Technologies, Inc. compare 38.4×
ILMN Illumina, Inc. compare 43.2×
WAT Waters Corporation compare 117×
NTRA Natera, Inc. compare 667×
Diagnostics & Research industry median 35.8×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on IDXX